Many men who have prostate cancer will die with it, rather than of it.
Since the 1980s, PSA tests have been used for the diagnosis and follow-up of prostate cancer. However, its use as a screening test for prostate cancer remains controversial.
Liquid biopsy is less invasive than standard biopsy, where a needle is put into a solid tumour to confirm a cancer diagnosis.
There are currently few effective and non-invasive methods to screen for early stages of cancer. But scientists have now developed a new blood test that promises to detect eight different cancers.
Even if they are not treated, only about three per cent of men will die of prostate cancer over their lifetime, most in their 70s or 80s.
A family physician and public health researcher explains why he isn't getting a prostate cancer test in Movember or at any time in the near future.
Basic anatomical knowledge can save lives.
Patients need to be at the centre of consultations about their treatment.
Men diagnosed with prostate cancer should be given all their options for treatment before they make a decision. In Australia today, this isn't the rule, but the exception.
Some conditions should be classified as normal in some people and don’t need treatment.
Australian health-care organisations are urging action on treatments of people who don't need them.
Two new studies are bursting the bubble about the value of screening men for prostate cancer.
Two major studies cast doubt on the value of screening for prostate cancer, yet it continues regardless.
Surgery to remove early-stage prostate cancer has serious side-effects including incontinence and impotence.
Many men live with prostate cancer rather than die from it. Here's the evidence for why they shouldn't jump to surgery.
The modern medical system is built on a one-on-one relationship between patient and physician.
(AP Photo/Jeff Barnard, File)
Cancer care is often impersonal, industrial and needlessly stressful. Allowing patients to witness personal introductions between their physicians would help ease their anxiety and build trust.
Digitized strand of DNA.
Genetic testing is revealing important information about disease risks, and consumers can now pay for a test to know their risk. They might be better off if their doctors considered these risks, too.
Tumour evolution was first identified 40 years ago. We're finally making good progress with it.
Radiotherapy treats cancer by directing beams of high energy x-rays at the tumour.
Getting the right amount of radiation is a fine balance between therapy and harm. A common way to improve the benefit-to-cure ratio is to fire multiple beams at the tumour from different directions.
Family practicing mindfulness together.
With changes to health care insurance on hold, now may be a good time to focus not on health insurance but on health. More and more studies show that we do have some control over that. Here's how.
We know obesity is bad for health - but most people don’t realise it’s implicated in causing many cancers.
Obesity is linked with a host of health outcomes. Both a disease itself and a risk factor linked to many others, we explore the linkages between obesity and cancer.
Mindfulness offered no benefit for reducing anxiety or distress in men with advanced prostate cancer.
Hold up: mindfulness training as a complementary therapy in cancer treatment might not work for everyone.
Though commonly associated with food poisoning, the strain of salmonella used is a benign variety.
What started with a study of diseases transmitted by mosquitos, could end with a new way of treating cancer.
Age-standardised cancer death rates have been falling in Australia.
Currently, seven cancer types are listed in the top 20 causes of death in Australia. These are cancers of the lung, blood and lymph, bowel, prostate, breast, pancreas, skin and some childhood cancers.
The cost of cancer drugs is killing patients and it needs to stop
Rectal examinations are less accurate than blood tests, missing more cancer and causing more false alarms.
In news which may come as a relief to apprehensive men and short-fingered doctors alike, guidelines are now changing.
Well-informed men see prostate cancer testing as an individual decision rather than a public health priority.
Miguel Pires da Rosa/Flickr
Screening for prostate cancer using the prostate specific antigen (PSA) test for men with no symptoms is controversial: experts are divided, and Australians are not routinely well-informed. Prostate cancer…